As expected, targeting the emerging cancer hallmarks and PCa-specific vulnerability genes, such as FASN and HMGCR [44,45], AIF treatment caused the attenuation of PCa cell growth, migration, and invasion. The gene discussed is HMGCR; the disease is posterior cortical atrophy.